| Comparator or background therapy8 trials |
|
Phase 2
|
NCT06177678 Comparator |
Feb → Sep 2024 |
ocular hypertension, open-angle glaucoma |
Kukje Pharma |
Unknown
|
No outcome recorded
|
|
Phase 3
|
NCT07617532 Comparator |
Jun 2026 → Mar 2028 expected |
ocular hypertension, open-angle glaucoma |
Ache Laboratorios Farmaceuticos S.A. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT05973318 Comparator |
Apr 2017 → Sep 2018 |
open-angle glaucoma |
Jadran Galenski laboratorij d.d. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00767481 Comparator |
Oct 2008 → Feb 2009 |
glaucoma, ocular hypertension |
Alcon Research |
Terminated
|
No outcome recorded
|
|
Phase 4
|
NCT00761995 Comparator |
Feb 2009 → Jul 2010 |
ocular hypertension, open-angle glaucoma |
Alcon Research |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT00796198 Comparator |
Dec 2008 → Jun 2009 |
glaucoma |
University of Turin, Italy |
Unknown
|
No outcome recorded
|
|
Phase 4
|
NCT00379834 Comparator |
Sep 2006 → Apr 2008 |
glaucoma |
West Virginia University |
Completed
|
No outcome recorded
|
| — |
NCT00804115 Comparator |
Aug 2000 → Sep 2007 |
exfoliation syndrome, ocular hypertension |
The New York Eye & Ear Infirmary |
Unknown
|
No outcome recorded
|
|